Accepted Manuscript Title: In vivo study of chitosan-natural nano hydroxyapatite scaffolds for bone tissue regeneration Author: Jong Seo Lee Sang Dae Baek Jayachandran Venkatesan Ira Bhatnagar Hee Kyung Chang Hui Taek Kim Se-Kwon Kim PII: DOI: Reference:

S0141-8130(14)00225-6 http://dx.doi.org/doi:10.1016/j.ijbiomac.2014.03.053 BIOMAC 4265

To appear in:

International Journal of Biological Macromolecules

Received date: Revised date: Accepted date:

12-2-2014 19-3-2014 26-3-2014

Please cite this article as: http://dx.doi.org/10.1016/j.ijbiomac.2014.03.053 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

1

In vivo study of chitosan-natural nano hydroxyapatite scaffolds for bone tissue

2

regeneration

3

Jong Seo Lee a, Sang Dae Baek b, Jayachandran Venkatesanc, Ira Bhatnagard, Hee Kyung Change, Hui



Taek Kima and Se-Kwon Kim c

5

a

6

b

7

c

8

University, Busan, 608-737, Republic of Korea

9

d

10

e

Department of Orthopaedic Surgery, Pusan National University Hospital, Busan 602-739, Republic of Korea

cr

Department of Medicine, Graduate School, Pusan National University, Busan, 602-739, Republic of Korea

us

Department of Marine Bio Convergence Science and Marine Bioprocess Research Center, Pukyong National

Nanotheranostics Laboratory, Centre for Cellular and Molecular Biology, Hyderabad 500-007, India

an

Department of Pathology, Medical College, Kosin University, Busan, 602-739, Republic of Korea

11 Abstract

M

12



ip t

4

Significant development has been achieved with bioceramics and biopolymer scaffolds in

14

the construction of artificial bone. In the present study, we have developed and compared

15

chitosan-micro hydroxyapatite (chitosan-mHA) and chitosan-nano hydroxyapatite (chitosan-

16

nHA) scaffolds as bone graft substitutes. The biocompatibility and cell proliferation of the

17

prepared scaffolds were checked with preosteoblast (MC3T3-E1) cells. Total Volume (TV),

18

Bone Volume (BV), Bone Surface (BS), Trabecular Thickness (Tb.Th), Trabecular Number

19

(Tb.N) and Trabecular Separation (Tb.Sp) were found to be higher in chitosan-nHA than

20

chitosan-mHA scaffold. Hence, we suggest that chitosan-nHA scaffold could be a promising

21

biomaterial for bone tissue engineering.

Ac ce p

te

d

13



Corresponding author; Department of Orthopaedic Surgery, Pusan National University Hospital, 1-10 Ami-dong, Seo-gu, Busan 602-739, Korea TEL:+82-51-240-7248 FAX:+82-51-247-8395 E- [email protected] Tel: +82 51 629 7097; Fax: +82 51 628 8147. E-mail address: [email protected]; [email protected]

1

Page 1 of 23

22

Keywords: Chitosan; Natural Hydroxyapatite; Marine Biomaterials.

23

1.

Introduction The repair and replacement of injured or defect bone is a critical problem in orthopedic

25

treatment worldwide. In recent years, significant development has been made in organ

26

replacement, surgical reconstruction and the use of artificial prostheses to treat the loss or failure

27

of an organ or tissue [1]. Autograft and allograft are considered as ideal procedures for bone

28

grafting. However, both grafting procedures have own disadvantages such as insufficient donor

29

site, secondary operation and transmissible diseases (HIV and diabetics). These drawbacks could

30

be overwhelmed by synthetic graft by using metals, ceramics and polymers. Nano based

31

synthetic graft biomaterials for tissue-engineering treatments are being explored for a better

32

treatment of bone related ailments. Numerous techniques and biomaterials have been employed

33

for the orthopedic treatment for the past several decades [2, 3].

d

M

an

us

cr

ip t

24

Chitosan is a natural biopolymer consisting of β-(1→4)-2-acetamido-d-glucose and β-

35

(1→4)-2-amino-d-glucose unit linkage [4, 5] and a promising biomaterial for bone tissue

36

engineering. In addition, chitosan can be easily modified into various forms like films, fibers,

37

beads, sponges and more complex shapes for orthopedic treatment [6-8]. The drawbacks of

38

chitosan scaffolds are flexibility and poor mechanical properties, which are inferior to those of

39

normal bone, because of which, they are unable to support load bearing bone implants. Calcium

40

phosphate mineral, hydroxyapatite [Ca10(PO4)6(OH)2] (HA) is considered to play a vital role in

41

various fields including spinal fusion, craniomaxillofacial reconstruction, bone defects, fracture

42

treatment, total joint replacement (bone augmentation) and revision surgery [9, 10]. Micro HA

43

(mHA) and nano HA (nHA) can be made either synthetically [11, 12] or isolated from natural

44

sources [13]. However, instead of natural HA, the composite of chitosan with synthetic HA is

Ac ce p

te

34

2

Page 2 of 23

more widely used as a bone graft substitute [1]. The addition of calcium phosphate in the

46

chitosan scaffold has been shown to increase cell adhesion, cell proliferation, mechanical

47

strength, alkaline phosphatase activity, protein adsorption, Type I collagen production as well as

48

expression of other osteogenic differentiation markers [1, 14-39]. The combination of chitosan-

49

nHA with stem cells and growth factors has recently emerged as a new strategy for promoting

50

bone regeneration [40, 41].

cr

ip t

45

Different kind of methods have been used to prepare the HA from natural bone such as

52

thermal calcination, alkaline hydrolysis and subcritical water method [42-44]. Thermal

53

calcination method usually produces mHA, whereas, alkaline hydrolysis method, produces

54

cabonated nHA [42]. Literature suggests that carbonated HA has comparatively higher

55

osteoconduction, bio resorption and biocompatibility with regard to bone formation [45, 46] than

56

synthetic HA. Naturally derived mHA combined chitosan has already been investigated for bone

57

formation [47, 48]. In the present study, we are intended to compare the effect of particle size of

58

HA in bone formation. In the present study, mHA and nHA particles isolated from marine fish

59

bone [42] have been used to prepare chitosan-mHA and Chitosan-nHA scaffolds with freeze-

60

drying method to be used as bone graft substitutes. The prepared scaffolds were subjected to in

61

vivo study with rabbit model and the Total Volume (TV), Bone Volume (BV), Bone Surface

62

(BS), Trabecular Thickness (Tb.Th), Trabecular Number (Tb.N) and Trabecular Separation

63

(Tb.Sp) were measured.

64

2.

Ac ce p

te

d

M

an

us

51

Materials and methods

65

Chitosan (310 KDa; Degree of deacetylation 90%) was purchased from Kitto Chemicals,

66

South Korea. mHA and nHA were isolated from Thunnus obesus bone as per previous literature

67

[42]. Osteoblast MC3T3-E1 cell line was obtained from American Type Culture Collection

3

Page 3 of 23

(Manassas, VA, USA). Dulbecco’s Modified Eagle’s Medium (DMEM) was obtained from

69

Gibco BRL, Life Technology. MTT (3-(4,5-dimethyl-2-yl)-2,5-diphenyltetrazolium bromide)

70

was purchased from Molecular Probes (Eugene, OR, USA). Other reagents used in this study

71

were all of analytical grade.

72

2.1.

ip t

68

cr

Preparative procedure of Chitosan-mHA and Chitosan-nHA scaffold

Chitosan-mHA and Chitosan-nHA were prepared according to previous literature with

74

slight modification [49, 50]. Briefly, 2.5 g of chitosan was dissolved in 250 ml of 2% acetic acid

75

solution. The solution was stirred overnight on a mechanical stirrer (RW 20.n Labortechik) and

76

sonicated for 1 h to remove any air bubbles. 2.5 g each of tuna bone derived mHA and nHA were

77

suspended separately in 50 ml of water and carefully transferred into the chitosan solution

78

prepared as described before, with the help of a dropper. The solution was mechanically stirred

79

for 24 h to disperse the HA particles in the polymer matrix in a homogeneous manner. The milky

80

white resultant solution was then transferred to small petri dish (35 x 10 mm) with 5 to 6 g of

81

solution/dish to freeze at -80 °C for 5 h and finally lyophilized in freeze dryer to form scaffolds.

82

These scaffolds were immersed in 10% NaOH solution for 1 d and then washed with excess

83

amount of water till the pH became neutral. All the neutralized scaffolds were then lyophilized

84

again to make them ready for experimentation. Morphology of scaffolds were studied by

85

Scanning Electron Microscopy (SEM HITACHI S-2400, Japan)

86

2.2.

Ac ce p

te

d

M

an

us

73

Cytotoxicity Study

87

MC3T3-E1 cells (Osteoblast cell line) were cultured in alpha-MEM medium

88

supplemented with 5% fetal bovine serum, 2mM glutamine and 100 µg/ml penicillin-

89

streptomycin and incubated at 37 °C, humidified atmosphere with 5% CO2. The in vitro effects

90

(cytotoxicity and cell proliferation) of scaffolds on MC3T3-E1 were determined by measuring 4

Page 4 of 23

MTT dye. Human osteoblast cell with 90% confluence obtained from cell culture flask (75cm2,

92

filter cap) were used to seed onto the scaffolds and investigate the cytocompatibility and cell

93

proliferation of chitosan and their composite scaffolds. Earlier to cell seeding, the scaffolds were

94

placed in 24-well culture plate with 400µl of cell culture media and incubated for 4 h at 37 °C in

95

a humidified incubator with 5% CO2 and 95% air. 100 µl of 5 x103 cells were seeded drop wise

96

onto the top of the scaffolds, allowing cells to distribute throughout the scaffolds. Consequently,

97

the cell-seeded scaffolds were kept at 37 °C in a humidified incubator with 5% CO2 for 4 h in

98

order to allow the cells to attach to the scaffolds. Fresh medium was replaced every 2 days till

99

the cultivation period. Three replicates were used for each scaffold type experiment.

cr

us

an

2.3.

In vitro cell proliferation assay

M

100

ip t

91

Cell viability on the scaffolds was measured using MTT (3-(4, 5-dimethylthiazol-2-yl)-2,

102

5-diphenyltetrazolium bromide) assay (Sigma, St. Louis, USA). Cleavage of the tetrazolium

103

rings turns the pale yellow MTT into dark blue formazan, the concentration of which is directly

104

proportional to the number of metabolically active cells. This reduction takes place only when

105

mitochondrial reductase enzymes are active. The media on the scaffolds were removed on the

106

respective days and incubated with fresh culture medium containing 400 µl of MTT (5 mg ml−1

107

medium) at 37 °C for 4 h in darkness. Then the unreacted dye was removed and 400 µl of

108

DMSO was added to dissolve the intracellular insoluble purple formazan product into a colored

109

solution. The absorbance of this solution was quantified by spectrophotometer at 540 nm with

110

aGENios® microplate reader (Tecan Austria GmbH, Austria). Cell viability and proliferation of

111

cells was quantified as a percentage compared to that of control.

Ac ce p

te

d

101

5

Page 5 of 23

112

2.4.

In vivo Study A total of 32 New Zealand White Rabbits (3.5-4.5Kg in weight) were used in this study.

114

The rabbits were separated into Group A and Group B. In Group A, 8 rabbits were used for

115

chitosan-mHA, whereas, in Group B, 6 rabbits were used for chitosan-nHA according to

116

materials inserted into bone gap.

ip t

113

The rabbit were anesthetized using a mixture of Ketamine (5 mg/kg), Xylazine (0.25

118

mg/kg) and Acepromazine (0.75 mg/kg). The tibia of the rabbit was shaved and draped with 10

119

% Betadine solution. In rabbit’s tibia, four 0.062-inch diameter K-wires were inserted from the

120

lateral aspect pointing towards the center of the medullary cavity. The most proximal K-wire was

121

aimed at the proximity of the tibial tuberosity, and the next K-wire was inserted at 1 cm interval

122

below the first one whereas the third K-wire was inserted at 2 cm interval below the second one,

123

the fourth 1cm below the third one in the same manner.

d

M

an

us

cr

117

External fixators (Dyna-Exter-(ST) Finger: Dynamic External Fixator for finger with

125

distraction and compression, BK Meditech, Seoul, Korea) were applied on both sides of the tibia

126

following K-wire insertion. A longitudinal skin incision between the second and third K-wires

127

was made through the anterior tibial crest and the muscles as well as periosteums were carefully

128

dissected. Osteotomy was then performed in the diaphysis with a 1-mm diameter dental drill, run

129

at low speed. Intermittent sterilized normal saline was dropped to avoid bony necrosis at the

130

osteotomy site. 1.5 cm of diaphyseal bone was excised between the second and third K-wire. In

131

the bony defect area, chitosan-mHA and chitosan-nHA composites scaffolds were inserted

132

carefully in both the experimental groups, respectively. Periosteum and skin were repaired with

133

4-0 nylon suture threads. To prevent inflammation, Kanamycin (15 mg/kg, once a day) was

Ac ce p

te

124

6

Page 6 of 23

134

injected intramuscularly for three consecutive days. Radiography (anteroposterior view of the

135

tibia) was performed every 2 weeks to monitor the process of bone formation.

136

2.5.

ip t

Histologic examination Histologic examination was performed when the rabbits were sacrificed. All rabbits were

138

killed by intravenous injection of pentobarbital (150 mg/kg) followed by potassium phosphate.

139

In order to prevent fracture or deformity in the bone gap area while harvesting the sample, tibias

140

were removed with the external fixator still in place, and preserved in a 4% neutral formalin

141

solution. Histologic samples were taken from one end of the defect to the other end including

142

areas where it joined the original bone. Bone tissues were fixed in phosphate buffer containing

143

10% formalin and then cleaned by immersion in 10% nitric acid for 1 week. The specimens were

144

embedded in paraffin, and 4μm sections were cut and stained with Hematoxylin-Eosin and

145

Masson-Trichrome stains. Histologic observation was done with a light microscope at 40X and

146

100X magnification.

147

2.6.

te

d

M

an

us

cr

137

Ac ce p

Micro-computed tomography (µCT) analysis

148

Micro-computerized tomographic evaluation was performed for the newly formed bone in

149

all rabbits and the trabecular patterns and its quality were measured. All specimens were scanned

150

with a high-resolution micro-computed tomography (µCT) system (Skyscan 1173; SKYSCAN,

151

Kontich, Belgium) at a resolution of 29.8 μm pixel. Source voltage was 130 kV, source current

152

was 25 µA, with a 1.0 mm aluminium filter and 250 ms exposure time. The images were

153

reconstructed using NRecon software. Region of interest (ROI) was defined as from proximal to

154

distal interface between original bone and bony defect on both ends in longitudinal section, as

155

defined as from medial tibial cortex to lateral tibial cortex except fibular portion in frontal

156

section, as around outer cortical margins excluding soft tissue portion in axial section.

7

Page 7 of 23

157

Parameters determined in the metaphyseal trabecular bone included Total volume (TV), bone

158

volume (BV), percent bone volume (BV/TV), bone surface density (BS/TV), trabecular number

159

(Tb.N), trabecular thickness (Tb.Th) and trabecular separation (Tb.Sp).

160

2.7.

ip t

161

Statistical analysis

All the data were expressed as means ± standard deviation of a minimum of three replicates for each scaffold in each experiment, measured by Graphpad Prism 5.

163

3.

Results and discussion

164

3.1.

Gross Examination of the scaffolds

us

cr

162

Scanning electron microsgraph images of chitosan-mHA and chitosan-nHA have been

166

shown in the Fig. 1 mHA and nHA have been isolated as per previous literature [42]. mHA

167

scaffolds were obtained in pure white color, whereas, nHA were slight yellow in color. However,

168

the both the prepared scaffolds are in pure white color.

169

3.2.

te

Cell Proliferation Assay

d

M

an

165

Scaffold for bone tissue engineering requires highly porous structure to ensure that the

171

biological environment is conductive to cell attachment, proliferation, tissue growth and

172

adequate nutrient flow [51]. The cytotoxic and cell proliferative effects of respective scaffolds

173

were investigated through MTT assay. The chitosan and its scaffolds were not found to be

174

cytotoxic to MC3T3-E1 cell line. Fig. 2 depicts the MC3T3-E1 cell proliferation on chitosan and

175

their mHA and nHA composite scaffolds as the function of time, measured by MTT assay which

176

represents active mitochondrial activity of living cells. The cell viability of chitosan-nHA

177

scaffolds was higher than that of chitosan-mHA scaffold; this might be due to the presence and

178

proper distribution of HA in the scaffold. Nanophase ceramics have superior capacity to

179

osteoblast adhesion then compared to micron-sized ceramics [52].

Ac ce p

170

8

Page 8 of 23

180

3.3.

Radiological evaluation Chitosan-mHA and chitosan-nHA scaffolds were fixed in the defective area of rabbit

182

tibia. Ten of these rabbits were alive more than 8 weeks after surgery, and the six (3 rabbits in

183

each), which successfully completed all the process without wound infection and fractures were

184

selected for this study. First, the defect regions were analyzed by radiography to evaluate

185

healing, every two weeks after operation (Fig. 3). In-group A (chitosan-mHA), substantial

186

detectable changes were not seen within 4 weeks on radiographic images. Marginal changes

187

were observed at 6 weeks on an anteroposterior image and only a small amount of bone

188

formation was observed at lateral aspect of the distal end of tibia. Clearly, no solid union was

189

achieved in Group A by 8 weeks postoperatively. Most area of defect exclusive of bone

190

formation showed even white density, which was assumed to originate from inserted material. In

191

group B (chitosan-nHA), overall sequential change was similar to the one of group A. Up to 4

192

weeks, no remarkable changes were visible on any radiographic images. On the images checked

193

at 6 and 8 weeks, not only marginal changes but also bony consolidation were apparent as

194

compared with group A. In most remaining part within defect, increase in white density was also

195

scanty. In group A, all 3 were graded as “poor” and in group B, 2 were graded as “fair” but one

196

was also estimated as “poor”.

197

3.4.

199

cr

us

an

M

d

te

Ac ce p

198

ip t

181

Micro-CT evaluation

Microcomputed tomography (µCT) is fully nondestructive and well suited for assessing truly three-dimensional (3D) microstructural bone properties.

200

The longitudinal reconstructions of the rabbit tibia 8 weeks postoperatively are shown in

201

Fig. 4. Group A shows cortical bone formation stemming from distal end to proximal end on

202

lateral side and small bony particles within implanted material. Group B also shows cortical bone

9

Page 9 of 23

formation on lateral side but differs from group A in the sense that the formation was made on

204

both proximal and distal ends. 3D reconstruction images make us to identify differences between

205

group A and group B more clearly. Marginal cortical bone formation in group A looks like a

206

narrow stalk and small bony particles are scattered irregularly in embedded material. In group B,

207

the regenerated bone at both the proximal and distal ends were observed greater than group A

208

around interfaces. Additionally, implanted materials were distributed more evenly within the

209

remaining defect. Values for structural parameters measured in μCT are presented in Table 1.

210

Comparing the two groups, BV/TV, Tb.Th, Tb.N are higher in Group B than in Group A and

211

Tb.Sp is higher in Group A than in Group B.

212

3.5.

an

us

cr

ip t

203

Histological evaluation

All microscopic examination showed that the bony defect was filled with amorphous

214

implanted material and degenerated cells. In group A, there was no distinct evidence of

215

ossification. Additionally, implanted material did not adhere to original bone, so free gap existed

216

in nearly whole interface area. Some of the defects were partially filled with degenerated

217

amorphous biomaterial. In group B, most defect area was also filled with implanted material

218

mixed with degenerated cells. But some margins of defect showed evidence of focal ossification

219

and implanted material adhered to original bone in a wider area (Fig. 5 (I & II). From this

220

observation, nHA plays superior role in the bone ossification.

221

4.

Ac ce p

te

d

M

213

Conclusion

222

We have developed chitosan-mHA and chitosan-nHA composite scaffolds by freeze

223

drying method to mimic the function of extracellular matrix of bone. Total volume, Bone

224

volume, Bone surface, Trabecular thickness, Trabecular number, Trabecular separation in nHA

225

containing chitosan polymer were found to be higher than chitosan-mHA scaffolds.

10

We

Page 10 of 23

226

conclude that chitosan-nHA is a suitable composite scaffold that will have great potential

227

applications in the field of bone tissue engineering.

228

Acknowledgement This research was supported by a grant from Marine Bioprocess Research Center of the

ip t

229

Marine Biotechnology Program funded by the Ministry of Oceans and Fisheries, Republic of

231

Korea.

232

References

233

[1] W. Thein-Han, R. Misra, Acta Biomater., 5 (2009) 1182-1197.

234

[2] J. Venkatesan, S.-K. Kim, Mar. Drugs, 8 (2010) 2252-2266.

235

[3] S. Sowmya, J.D. Bumgardener, K.P. Chennazhi, S.V. Nair, R. Jayakumar, Prog. Polym. Sci.,

us

an

38, (2013) 1748-1772 .

M

236

cr

230

[4] J. Je, S. Kim, Bioorgan. Med. Chem., 13 (2005) 6551-6555.

238

[5] Y. Jeon, F. Shahidi, S. Kim, Food Rev. Int., 16 (2000) 159-176.

239

[6] J. Venkatesan, Z.J. Qian, B. Ryu, N. Ashok Kumar, S.K. Kim, Carbohyd. Polym., 83 (2011)

241 242

te

569-577.

Ac ce p

240

d

237

[7] R. Pallela, J. Venkatesan, V.R. Janapala, S.-K. Kim, J. Biomed. Mater. Res. A, 100A (2012) 486-495.

243

[8] R. Jayakumar, M. Prabaharan, S.V. Nair, H. Tamura, Biotechnol. Adv., 28 (2010) 142-150.

244

[9] L.C. Palmer, C.J. Newcomb, S.R. Kaltz, E.D. Spoerke, S.I. Stupp, Chem. Rev., 108 (2008)

245

4754-4783.

246

[10] S.M. Best, A.E. Porter, E.S. Thian, J. Huang, J. Eur. Ceram. Soc., 28 (2008) 1319-1327.

247

[11] G. Bezzi, G. Celotti, E. Landi, T. La Torretta, I. Sopyan, A. Tampieri, Mater. Chem. Phys.,

248

78 (2003) 816-824.

11

Page 11 of 23

[12] S. Koutsopoulos, J. Biomed. Mater. Res., 62 (2002) 600-612.

250

[13] S. Joschek, B. Nies, R. Krotz, A. Göpferich, Biomaterials, 21 (2000) 1645-1658.

251

[14] L. Kong, Y. Gao, G. Lu, Y. Gong, N. Zhao, X. Zhang, Eur. Polym. J., 42 (2006) 3171-3179.

252

[15] L. Kong, Y. Gao, W. Cao, Y. Gong, N. Zhao, X. Zhang, J. Biomed. Mater. Res. A, 75

253

(2005) 275-282.

ip t

249

[16] R. Murugan, S. Ramakrishna, Biomaterials, 25 (2004) 3829-3835.

255

[17] S. Saravanan, S. Nethala, S. Pattnaik, A. Tripathi, A. Moorthi, N. Selvamurugan, Int. J.

259 260

us

an

258

[18] L. Jiang, Y. Li, X. Wang, L. Zhang, J. Wen, M. Gong, Carbohyd. Polym., 74 (2008) 680684.

[19] C. Xianmiao, L. Yubao, Z. Yi, Z. Li, L. Jidong, W. Huanan, Mater. Sci. Eng. C, 29 (2009)

M

257

Biol. Macromol., 49 (2011) 188-193.

29-35.

d

256

cr

254

[20] J. Liuyun, L. Yubao, X. Chengdong, J. Biomed. Sci., 16 (2009) 65.

262

[21] Z. Huang, Q. Feng, B. Yu, S. Li, Mater. Sci. Eng. C, 31 (2011) 683-687.

263

[22] Y. Zhang, J.R. Venugopal, A. El-Turki, S. Ramakrishna, B. Su, C.T. Lim, Biomaterials, 29

265 266

Ac ce p

264

te

261

(2008) 4314-4322.

[23] M. Peter, N. Ganesh, N. Selvamurugan, S. Nair, T. Furuike, H. Tamura, R. Jayakumar, Carbohyd. Polym., 80 (2010) 687-694.

267

[24] I. Manjubala, S. Scheler, J. Bössert, K.D. Jandt, Acta Biomater., 2 (2006) 75-84.

268

[25] Z. Huang, B. Yu, Q. Feng, S. Li, Y. Chen, L. Luo, Carbohyd. Polym., 85 (2011) 261-267.

269

[26] Z. Li, L. Yubao, Y. Aiping, P. Xuelin, W. Xuejiang, Z. Xiang, J. Mater. Sci.: Mater. Med.,

270 271

16 (2005) 213-219. [27] F. Chen, Z.-C. Wang, C.-J. Lin, Mater. Lett., 57 (2002) 858-861.

12

Page 12 of 23

273 274 275

[28] L. Zhang, Y.-b. Li, J. Wei, Y. Zuo, J.-m. Han, L. Wu, X.-j. Wang, J. Funct. Mater., 3 (2005) 012. [29] S.H. Teng, E.J. Lee, B.H. Yoon, D.S. Shin, H.E. Kim, J.S. Oh, J. Biomed. Mater. Res. A, 88 (2009) 569-580.

ip t

272

[30] K.S. Katti, D.R. Katti, R. Dash, Biomed. Mater., 3 (2008) 034122.

277

[31] X. Cai, H. Tong, X. Shen, W. Chen, J. Yan, J. Hu, Acta Biomater., 5 (2009) 2693-2703.

278

[32] J.D. Chen, Y. Wang, X. Chen, J. Biomater. Sci. Polym. Ed., 20 (2009) 1555-1565.

279

[33] Q. Hu, B. Li, M. Wang, J. Shen, Biomaterials, 25 (2004) 779-785.

280

[34] Y.-F. Zhang, X.-R. Cheng, Y. Chen, B. Shi, X.-H. Chen, D.-X. Xu, J. Ke, J. Biomater.

284 285

us

an

M

283

[35] J. Li, D. Zhu, J. Yin, Y. Liu, F. Yao, K. Yao, Materials Science and Engineering: C, 30 (2010) 795-803.

d

282

Appl., 21 (2007) 333-349.

[36] Y. Chen, S. Li, X. Li, Y. Zhang, Z. Huang, Q. Feng, Z. Zhou, B. Lin, B. Yu, J. Nanomater., 2012 (2012) 5.

te

281

cr

276

[37] X. Li, K. Nan, S. Shi, H. Chen, Int. J. Biol. Macromol., 50 (2012) 43-49.

287

[38] S.E. Kim, H.W. Choi, H.J. Lee, J.H. Chang, J. Choi, K.J. Kim, H.J. Lim, Y.J. Jun, S.C. Lee,

288

Ac ce p

286

J. Mater. Chem., 18 (2008) 4994-5001.

289

[39] F. Wang, Y.C. Zhang, H. Zhou, Y.C. Guo, X.X. Su, J. Biomed. Mater. Res. A, (2013).

290

[40] H. Liu, H. Peng, Y. Wu, C. Zhang, Y. Cai, G. Xu, Q. Li, X. Chen, J. Ji, Y. Zhang,

291 292 293

Biomaterials, 34 (2013) 4404-4417. [41] S. Tavakol, M. Nikpour, A. Amani, M. Soltani, S. Rabiee, S. Rezayat, P. Chen, M. Jahanshahi, J. Nanopar. Res., 15 (2013) 1-16.

13

Page 13 of 23

295 296 297

[42] J. Venkatesan, Z.J. Qian, B. Ryu, N.V. Thomas, S.K. Kim, Biomed. Mater., 6 (2011) 035003. [43] N.A. Barakat, M.S. Khil, A. Omran, F.A. Sheikh, H.Y. Kim, J. Mater. Process. Tech., 209 (2009) 3408-3415.

ip t

294

[44] J. Venkatesan, S.K. Kim, Materials, 3 (2010) 4761-4772.

299

[45] E. Landi, G. Celotti, G. Logroscino, A. Tampieri, J. Eur. Ceram. Soc., 23 (2003) 2931-2937.

300

[46] T.E. Orr, P.A. Villars, S.L. Mitchell, H.P. Hsu, M. Spector, Biomaterials, 22 (2001) 19531959.

us

301

cr

298

[47] X.-J. Tang, et al., Biomed. Mater., 3 (2008) 044115.

303

[48] H. Yuan, N. Chen, X. Lü, B. Zheng, Journal of Nanjing Medical University, 22 (2008) 372-

306

M

[49] J. Venkatesan, Z.-J. Qian, B. Ryu, N. Ashok Kumar, S.-K. Kim, Carbohyd. Polym., 83 (2011) 569-577.

d

305

375.

te

304

an

302

[50] J. Venkatesan, S.K. Kim, Adv. Mater. Res., 584 (2012) 212-216.

308

[51] B. Dhandayuthapani, Y. Yoshida, T. Maekawa, D.S. Kumar, Int. J. Polym. Sci., 2011

309 310 311 312 313

Ac ce p

307

(2011) 19 pages.

[52] T.J. Webster, R.W. Siegel, R. Bizios, Biomaterials, 20 (1999) 1221-1227.

14

Page 14 of 23

313

Figure Captions

314

Fig. 1 Scanning electron microcopic images of (A and B) chitosan-mHA and (C and D) chitosan-

315

nHA. Fig. 2 Viability of MC3T3-E1 osteoblast like cell on chitosan and their mHA and nHA

317

composite scaffolds as the function of time, measured by MTT assay which represents

318

active mitochondrial activity of living cells. Cell density was significantly higher on the

319

composite scaffold after day 5 onwards, (n=3).

cr

ip t

316

Fig. 3 Micro-CT evaluation (A) Coronal longitudinal section (group A), (B) Coronal longitudinal

321

section (group B), (C and D) 3D reconstruction image (group A) and (E and F) 3D

322

reconstruction image (group B) for bone regeneration and remodeling in the bone defect.

324

Fig. 4 Serial radiographs of groups A (Chitosan-mHA) and group B (Chitosan - nHA) for bone

an

323

us

320

formation.

Fig 5. Fig. 5 (I) Microscopic findings of new bone at 8 weeks after transplantation of chitosan-

326

mHA (A & B) Microscopic examination showed the bony defect filled with biomaterial

327

() (H-E, 20X), no distinct ossification was seen, (C) Bony defect was filled with

328

biomaterial () and osteoblasts () (H-E 100X), (D) The defect was partially filled with

329

osteoid islands () and degenerated amorphous biomaterial mixed with osteoblasts ()

330

(H-E, 100X)

te

d

M

325

Fig. 5 (II) Microscopic findings of new bone at 8 weeks after transplantation of chitosan-nHA

332

(A & B) Microscopic examination showed that the bony defect was filled with

333

biomaterial mixed with osteoblasts () (A: H-E, 20X, B: 100X) (C) The margin of defect

334

showed the biomaterial and cells associated with ossification ( ) (H-E, 200X) (D) The

335

margin of defect shows bone trabeculae (⏎) and a few islands of ossification () (H-E,

336

100X).

337

Ac ce p

331

338

15

Page 15 of 23

nHA

ce

pt

ed

M an

mHA

u

Graphical Abstract

Chitosan-nHA

Ac

Chitosan-mHA

Page 16 of 23

Figure(s)

(A)

us

cr

ip t

(B)

(D)

d

M

an

(C)

Ac ce p

chitosan-nHA.

te

Fig. 1 Scanning electron microcopic images of (A and B) chitosan-mHA and (C and D)

1

Page 17 of 23

1st Day 3rd Day 5th Day 7th Day

0.6

ip t

0.4 0.2

cr

Absorbance @540nm

0.8

Ch

itos

a

m n-

HA Ch

io

tsan

nH

an

Scaffold Type

A

us

0.0

M

Fig. 2 Viability of MC3T3-E1 osteoblast like cell on chitosan and their mHA and nHA composite scaffolds as the function of time, measured by MTT assay, which

d

represents active mitochondrial activity of living cells. Cell density was

Ac ce p

te

significantly higher on the composite scaffold after day 5 onwards, (n=3).

2

Page 18 of 23

(B)

(C)

cr

ip t

(A)

M

an

us

(D)

(F)

Ac ce p

te

d

(E)

Fig. 3 Micro-CT evaluation (A) Coronal longitudinal section (group A), (B). Coronal longitudinal section (group B), (C and D) 3D reconstruction image (group A) and (E and F) 3D reconstruction image (group B) for bone regeneration and remodeling in the bone defect.

3

Page 19 of 23

PostOP (12.05.31)

12.06.21 (4w)

12.06.07 (2w)

12.07.5 (6w)

12.07.19 (8w)

Ac ce p

te

d

M

an

Group B Chitosan-nHA

us

PreOP (12.05.29)

cr

ip t

Group A Chitosan-mHA

PreOP (12.05.29)

PostOP (12.05.31)

12.6.14 (2w)

12.06.21 (4w)

12.07.06 (6w)

12.07.20 (8w)

Fig. 4 Serial radiographs of groups A (Chitosan-mHA) and group B (Chitosan - nHA) for bone formation.

4

Page 20 of 23

ip t cr us an M d

te

Fig. 5 (I) Microscopic findings of new bone at 8 weeks after transplantation of chitosan-

Ac ce p

mHA (A & B) Microscopic examination showed the bony defect filled with biomaterial () (H-E, 20X), no distinct ossification was seen, (C) Bony defect was filled with biomaterial () and osteoblasts () (H-E 100X), (D) The defect was partially filled with osteoid islands () and degenerated amorphous biomaterial mixed with osteoblasts () (H-E, 100X)

5

Page 21 of 23

ip t cr us an M d

te

Fig. 5 (II) Microscopic findings of new bone at 8 weeks after transplantation of chitosan-

Ac ce p

nHA (A & B) Microscopic examination showed that the bony defect was filled with biomaterial mixed with osteoblasts () (A: H-E, 20X, B: 100X) (C) The margin of defect showed the biomaterial and cells associated with ossification ( ) (H-E, 200X) (D) The margin of defect shows bone trabeculae (⏎) and a few islands of ossification () (H-E, 100X).

6

Page 22 of 23

Table 1. The average value of micro-CT parameters according to the group Group B

TV (mm3)

1179.449

1207.216

BV (mm3)

58.979

Percent bone volume, BV/TV (%)

5.001

BS (mm2) Bone surface density, BS/TV (mm2/ mm3)

an

0.944

Tb.Th (mm)

M

Tb.N (1/mm)

10.426

2160.444 1.790

0.458

0.709

0.109

0.147

1.228

0.757

d

Tb.Sp (mm)

125.864

us

1113.327

ip t

Group A

cr

Parameters

te

TV: Total volume, BV: Bone volume, BS: Bone surface, Tb.Th: Trabecular thickness,

Ac ce p

Tb.N: Trabecular number, Tb.Sp: Trabecular separation

8

Page 23 of 23

In vivo study of chitosan-natural nano hydroxyapatite scaffolds for bone tissue regeneration.

Significant development has been achieved with bioceramics and biopolymer scaffolds in the construction of artificial bone. In the present study, we h...
2MB Sizes 0 Downloads 4 Views